Beijing SL Pharmaceutical Co., Ltd.

¥5.15As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002038Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (11.77%)
Div yield 0.19%
ROE (15.96%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.03)
PE TTM —
TSR TTM (31.67%)
Mkt cap ¥5.291B
ROIC (0.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.34
23.11%
(76.25%)
Hold 4|12|1|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.06
0.07
11.86%
4.27%
2.29%
(4.46%)
Revenue¥M
265.0
261.2
262.4
258.0
6.98%
(0.14%)
(3.13%)
(3.68%)
Peers (US$793.1M)
Cap (US$)
PE
786.7M
49.56x
786.5M
14.53x
794.0M
71.29x
Capital
TTM
5Y
10Y
Leveragex
0.411
(0.259)
(0.237)
EBIT/Intx
1.005
1.984
1.765
Own earn%
38.96
77.78
82.09
Sh yield%
23.62
39.38
38.57
Owners
Insiders/Inst%
7.73
62.79
Short interest%
2.55
SBC / revenue%
1.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
3